Government and Academic Research Alliances
Creating Partnerships in Research
The Office supports research alliances at the University of Rochester, a leader and innovator in basic, translational, and clinical research and technology development.
Small Business Innovation Research (SBIR) and Other Resources to Support University Technology Commercialization
On October 8, 2021 the University of Rochester (UR) held a workshop for researchers focused on programs and resources to support technology development and commercialization, particularly Small Business Innovation Research (SBIR) & Small Business Technology Transfer (STTR) grants.
The workshop provided insight on the SBIR and STTR programs, including UR researchers sharing their experiences in how to develop successful proposals. Additional panelists also discussed available resources to support the development and commercialization of technologies. The UR research community is able to access the workshop recording, presentation slides and other materials here.
This Workshop was sponsored/organized by the Office of Government and Community Relations, NextCorps, UR Ventures, Office of Biomedical Research Development, and the Clinical and Translational Science Institute.
Empire Discovery Institute
University of Rochester, University at Buffalo and Roswell Park Comprehensive Cancer Center have joined together to form a powerful new drug discovery partnership that aims to convert the institutions’ scientific breakthroughs into viable pharmaceuticals for commercialization and strengthen the region as a hub for life sciences research and development.
The Empire Discovery Institute (EDI) is a not-for-profit drug discovery and development collaborative between three premiere Upstate New York academic, research, and clinical institutions—the University of Rochester, the University at Buffalo, and the Roswell Park Comprehensive Cancer Center. Its mission is to advance drug discovery throughout New York State.
The Empire Discovery Institute (EDI) represents a transformative approach to drug discovery and development. It sources innovative, commercially attractive drug discovery programs from its three collaborating academic centers (the University of Rochester, University at Buffalo and Roswell Park Comprehensive Cancer Center to address critical, unmet needs for patients. This new enterprise has been established with an initial grant and investment commitment of $35.4M over the next five years from the New York State Life Science Initiative.
One of the emerging disciplines of the 21st century, Data Science is the creation and application of powerful new methods to collect, curate, analyse, and make discoveries from large-scale data. The university has created a The Goergen Institute for Data Science to serve as a university-wide hub for data science-related research and educational programs, while further facilitating collaborations through a new state-of-the-art facility as a home for data science.
Jan 24, 2023
Researchers identify neurons that "learn" to smell a threat
Jan 19, 2023
Paula Vertino Takes the Reins as Leader of Basic Science at SMD
Jan 18, 2023
Pressing Issue: The High Incidence of Lung Cancer